METROPOLIS HEALTHCARE
|
METROPOLIS HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.17 | 27.99 | 24.95 | 27.90 | 41.86 |
| CEPS(Rs) | 15.67 | 12.27 | 10.88 | 11.36 | 13.58 |
| DPS(Rs) | 5.00 | - | 4.00 | 8.00 | 8.00 |
| Book NAV/Share(Rs) | 72.46 | 255.41 | 212.47 | 191.54 | 170.88 |
| Tax Rate(%) | 26.23 | 23.76 | 26.47 | 23.52 | 26.82 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.57 | 23.16 | 23.84 | 25.35 | 28.14 |
| EBIT Margin(%) | 17.50 | 16.13 | 16.77 | 19.10 | 25.92 |
| Pre Tax Margin(%) | 15.75 | 14.34 | 14.46 | 16.33 | 23.88 |
| PAT Margin (%) | 11.62 | 10.93 | 10.64 | 12.49 | 17.48 |
| Cash Profit Margin (%) | 19.74 | 19.10 | 18.46 | 20.26 | 22.62 |
| Performance Ratios | |||||
| ROA(%) | 7.98 | 7.25 | 7.43 | 8.30 | 15.31 |
| ROE(%) | 13.53 | 12.07 | 12.42 | 15.46 | 27.31 |
| ROCE(%) | 20.03 | 17.59 | 18.73 | 19.83 | 34.39 |
| Asset Turnover(x) | 0.69 | 0.66 | 0.70 | 0.66 | 0.88 |
| Sales/Fixed Asset(x) | 0.81 | 0.79 | 0.85 | 0.89 | 1.48 |
| Working Capital/Sales(x) | 12.23 | 25.80 | 17.26 | 30.41 | 13.41 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.23 | 1.27 | 1.17 | 1.12 | 0.68 |
| Receivable days | 35.29 | 37.60 | 37.50 | 40.91 | 38.40 |
| Inventory Days | 10.35 | 11.86 | 12.59 | 15.21 | 13.62 |
| Payable days | 143.56 | 153.03 | 145.60 | 142.17 | 141.34 |
| Valuation Parameters | |||||
| PER(x) | 47.33 | 13.96 | 69.19 | 44.76 | 48.66 |
| PCE(x) | 27.68 | 31.84 | 39.67 | 27.50 | 37.50 |
| Price/Book(x) | 5.99 | 6.12 | 8.13 | 6.52 | 11.92 |
| Yield(%) | 1.15 | - | 0.23 | 0.64 | 0.39 |
| EV/Net Sales(x) | 5.44 | 6.05 | 7.26 | 5.56 | 8.56 |
| EV/Core EBITDA(x) | 20.77 | 24.92 | 29.53 | 20.68 | 28.75 |
| EV/EBIT(x) | 31.07 | 37.53 | 43.30 | 29.09 | 33.02 |
| EV/CE(x) | 5.84 | 5.99 | 8.00 | 5.98 | 9.18 |
| M Cap / Sales | 5.46 | 6.08 | 7.32 | 5.57 | 8.48 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 23.64 | 10.23 | 5.18 | -6.52 | 23.08 |
| Core EBITDA Growth(%) | 33.20 | 8.88 | -3.73 | -15.62 | 21.16 |
| EBIT Growth(%) | 34.15 | 6.00 | -7.65 | -31.10 | 24.42 |
| PAT Growth(%) | 31.38 | 13.28 | -10.42 | -33.21 | 17.09 |
| EPS Growth(%) | -67.25 | 12.16 | -10.57 | -33.34 | 16.85 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.01 | - | 0.08 | 0.30 |
| Current Ratio(x) | 1.24 | 1.11 | 1.25 | 1.12 | 1.25 |
| Quick Ratio(x) | 1.16 | 1.01 | 1.11 | 0.98 | 1.11 |
| Interest Cover(x) | 9.97 | 8.99 | 7.26 | 6.89 | 12.72 |
| Total Debt/Mcap(x) | - | - | - | 0.01 | 0.02 |
Compare Financial Ratios of peers of METROPOLIS HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| METROPOLIS HEALTHCARE | ₹11,875.2 Cr | -1.6% | 4.9% | 9.6% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹125,093.0 Cr | -1.1% | -2.5% | 13.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹99,963.8 Cr | 3.7% | 1.7% | -10% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,360.8 Cr | -3.9% | -6% | -6.6% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹64,704.2 Cr | -6% | -9.8% | 19.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,755.0 Cr | 0% | 3.5% | 6.9% | Stock Analytics | |
METROPOLIS HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| METROPOLIS HEALTHCARE | -1.6% |
4.9% |
9.6% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses
